CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity

Blood

Volumn 101, Issue 8, 2003, Pages 3052-3057

  Fehniger, Todd A ^b   Cooper, Megan A ^b   Nuovo, Gerard J ^b   Cella, Marina ^b   Facchetti, Fabio ^b   Colonna, Marco ^b   Caligiuri, Michael A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN; TETANUS TOXOID;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; LYMPH NODE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ADULT; BIOLOGICAL MODEL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; COCULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; PHYSIOLOGY; SECRETION;

ADULT; ANTIGENS, CD; ANTIGENS, CD56; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; RECEPTORS, INTERLEUKIN-2; TETANUS TOXOID;

EID: 0037606040     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2876     Document Type: Article

References (49)

1. Paul WE. Fundamental Immunology. New York, NY: Lippincott-Raven; 1999.
2. Germain RN. The art of the probable: system control in the adaptive immune system. Science. 2001;293:240-245.
3. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5:405-411.
4. Feriazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343-351.
5. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med. 2002;195:335-341.
6. Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002;195:327-333.
7. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997;9:4-9.
8. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421-2438.
9. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633-640.
10. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol. 1998;10:298-305.
11. Lanier LL. Face off - the interplay between activating and inhibitory immune receptors. Curr Opin Immunol. 2001;13:326-331.
12. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001;19:291-330.
13. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
14. Scharton-Kersten TM, Sher A. Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol. 1997;9:44-51.
15. Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol. 1999;162:4511-4520.
16. bright subset. Blood. 2001;97:3146-3151.
17. Smith KA. Interleukin-2: inception, impact, and implications. Science. 1988;240:1169-1176.
18. Caligiuri MA, Zmuidzinas A, Manley TJ, et al. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 1990;171:1509-1526.
19. Caligiuri MA, Murray C, Robertson MJ, et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest. 1993;91:123-132.
20. Andre P, Spertini O, Guia S, et al. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci U S A. 2000;97:3400-3405.
21. dim natural killer cell subsets. J Immunol. 1998;161:400-408.
22. Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56x+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001;166:6477-6482.
23. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:305-310.
24. Nuovo GJ, MacConnell P, French DL. Correlation of the in situ detection of PCR-amplified metalloprotease cDNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 1995;55:267-275.
25. Nuovo GJ. PCR In Situ Hybridization Protocols and Applications. New York, NY: Lippincott-Raven Press; 1997.
26. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
27. Cella M, Nakajima H, Facchetti F, Hoffmann T, Colonna M. ILT receptors at the interface between lymphoid and myeloid cells. Curr Top Microbiol Immunol. 2000;251:161-166.
28. Vivier E, Munroe M, Ariniello P, Anderson P. Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells. Am J Pathol. 1995;146:409-418.
29. Ritchie AW, James K, Micklem HS. The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol. 1983;51:439-447.
30. Kummer JA, Kamp AM, Tadema TM, et al. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol. 1995;100:164-172.
31. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002;16:1-4.
32. Rosen SD, Hwang ST, Giblin PA, Singer MS. High-endothelial-venule ligands for L-selectin: identification and functions. Biochem Soc Trans. 1997;25:428-433.
33. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97:14-32.
34. Seder RA, Mosmann TR. Differentiation of effector phenotypes of CD4+ and CD8+ T cells. In: Paul WE, ed. Fundamental Immunology. New York, NY: Lippincott-Raven Press; 1999:879-908.
35. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17:138-146.
36. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med. 1988;168:543-558.
37. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation, I: IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol. 1988;140:4245-4252.
38. Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol. 1992;148:2142-2147.
39. Bradley LM, Dalton DK, Croft M. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol. 1996;157:1350-1358.
40. Ma X, Chow JM, Gri G, et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996;183:147-157.
41. Hayes MP, Wang J, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood. 1995;86:646-650.
42. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997;185:817-824.
43. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med. 1993;178:567-577.
44. Kos FJ, Engleman EG. Immune regulation: a critical link between NK cells and CTLs. Immunol Today. 1996;17:174-176.
45. Kos FJ, Engleman EG. Requirement for natural killer cells in the induction of cytotoxic T cells. J Immunol. 1995;155:578-584.
46. Kurosawa S, Harada M, Matsuzaki G, et al. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology. 1995;85:338-346.
47. Kos FJ, Engleman EG. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol. 1996;173:1-6.
48. Peritt D, Robertson S, Gri G, et al. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol. 1998;161:5821-5824.
49. Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1 -type 2 differentiation? Nat Immunol. 2001;2:917-924.